Synlett 2001; 2001(11): 1808-1810
DOI: 10.1055/s-2001-18106
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Stereoselective Synthesis of (3R,5R)-cis-3-Hydroxy-5-phenylpyrrolidine

Kenji Maeda* , Yuhei Yamamoto, Koji Tomimoto, Toshiaki Mase
  • *Process Research, Process R&D, Laboratories for Technology Development, Banyu Pharmaceutical Co., Ltd, Kamimutsuna 3-chome-9-1, Okazaki, Aichi 444-0858, Japan; Fax + 81(564)51 70 86; E-mail: maedakj@banyu.co.jp
Further Information

Publication History

Publication Date:
29 October 2001 (online)

Cis-3-hydroxy-5-phenyl pyrrolidine could be synthesized stereoselectively from inexpensive starting materials, (R)-(+)-ethyl-4-chloro-3-hydroxybutanoate and (R)-(+)-4-chloro-3-hydroxybutyronitrile. Key feature involves face- and chemo-selective hydrogenation of cyclic imine 5 as the common key intermediate using Pt/C catalyst. Transformations described here will allow a practical synthesis of novel carbapenems, 1 and 2.

    >